Table 3 Effect of dose on plasma-derived C1-inhibitor concentrate efficacy
500 U a (N = 13) | ≥ 1000 U a (N = 11) | |
|---|---|---|
Mean (SD) | ||
Body weight, kg | 68.8 (24.0) | 70.8 (12.6) |
Time between attack onset and injection, hours | 2.3 (1.1) | 3.3 (4.2) |
Shortening of attack with treatment, hours | 53.1 (25.9) | 58.8 (40.1) |
Time between injection and resolution of symptoms, hours | 27.6 (16.3) | 21.9 (11.3) |